Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Lees

Showing results (111-120 of 183) with videos related to

Pageof 19
Sort By:
Molecular Pharmaceutics|September 22, 2018
Preclinical Efficacy and Characterization of Candidate Vaccines for Treatment of Opioid Use Disorders Using Clinically Viable Carrier ProteinsFederico Baruffaldi, April Huseby Kelcher, Megan Laudenbach, et al.
Clinical and Vaccine Immunology : CVI|May 14, 2010
Functional T-cell deficiency in adolescents who experience serogroup C meningococcal disease despite receiving the meningococcal serogroup C conjugate vaccineRachel A Foster, Jennifer Carlring, Andrew Lees, et al.
Protein Expression and Purification|July 23, 2014
A scalable method for biochemical purification of Salmonella flagellinRaphael Simon, Brittany Curtis, Vehid Deumic, et al.
Infection and Immunity|May 8, 2013
Novel synthetic (poly)glycerolphosphate-based antistaphylococcal conjugate vaccineQuanyi Chen, Jay Dintaman, Andrew Lees, et al.
Plos One|February 21, 2012
Correlation of group C meningococcal conjugate vaccine response with B- and T-lymphocyte activityJames B Wing, Lynne Smart, Ray Borrow, et al.
Parkinsonism & Related Disorders|January 24, 2021
Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO studyRegina Katzenschlager, Werner Poewe, Olivier Rascol, et al.
Journal of Neuroinflammation|October 1, 2008
Mannan-Abeta28 conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) miceIrina Petrushina, Anahit Ghochikyan, Mikayel Mkrtichyan, et al.
Journal of Parkinson'S Disease|March 26, 2014
Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's diseaseIciar Aviles-Olmos, John Dickson, Zinovia Kefalopoulou, et al.
Infection and Immunity|August 3, 2011
Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidisRaphael Simon, Sharon M Tennant, Jin Y Wang, et al.
The Journal of Clinical Investigation|June 4, 2013
Exenatide and the treatment of patients with Parkinson's diseaseIciar Aviles-Olmos, John Dickson, Zinovia Kefalopoulou, et al.
Pageof 19

Showing results (111-120 of 183) with videos related to

Sort By:
Pageof 19
Molecular Pharmaceutics|September 22, 2018
Preclinical Efficacy and Characterization of Candidate Vaccines for Treatment of Opioid Use Disorders Using Clinically Viable Carrier ProteinsFederico Baruffaldi, April Huseby Kelcher, Megan Laudenbach, et al.
Clinical and Vaccine Immunology : CVI|May 14, 2010
Functional T-cell deficiency in adolescents who experience serogroup C meningococcal disease despite receiving the meningococcal serogroup C conjugate vaccineRachel A Foster, Jennifer Carlring, Andrew Lees, et al.
Protein Expression and Purification|July 23, 2014
A scalable method for biochemical purification of Salmonella flagellinRaphael Simon, Brittany Curtis, Vehid Deumic, et al.
Infection and Immunity|May 8, 2013
Novel synthetic (poly)glycerolphosphate-based antistaphylococcal conjugate vaccineQuanyi Chen, Jay Dintaman, Andrew Lees, et al.
Plos One|February 21, 2012
Correlation of group C meningococcal conjugate vaccine response with B- and T-lymphocyte activityJames B Wing, Lynne Smart, Ray Borrow, et al.
Parkinsonism & Related Disorders|January 24, 2021
Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO studyRegina Katzenschlager, Werner Poewe, Olivier Rascol, et al.
Journal of Neuroinflammation|October 1, 2008
Mannan-Abeta28 conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) miceIrina Petrushina, Anahit Ghochikyan, Mikayel Mkrtichyan, et al.
Journal of Parkinson'S Disease|March 26, 2014
Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's diseaseIciar Aviles-Olmos, John Dickson, Zinovia Kefalopoulou, et al.
Infection and Immunity|August 3, 2011
Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidisRaphael Simon, Sharon M Tennant, Jin Y Wang, et al.
The Journal of Clinical Investigation|June 4, 2013
Exenatide and the treatment of patients with Parkinson's diseaseIciar Aviles-Olmos, John Dickson, Zinovia Kefalopoulou, et al.
Pageof 19